Induction of antiviral genes by the tumor microenvironment confers resistance to virotherapy

por Liu, Yu-Ping, Suksanpaisan, Lukkana, Steele, Michael B., Russell, Stephen J., Peng, Kah-Whye
Publicado 2013

Mathematical Model for Radial Expansion and Conflation of Intratumoral Infectious Centers Predicts Curative Oncolytic Virotherapy Parameters

por Bailey, Kent, Kirk, Amber, Naik, Shruthi, Nace, Rebecca, Steele, Michael B., Suksanpaisan, Lukkana, Li, Xing, Federspiel, Mark J., Peng, Kah-Whye, Kirk, David, Russell, Stephen J.
Publicado 2013

Preclinical safety assessment of MV-s-NAP, a novel oncolytic measles virus strain armed with an H.pylori immunostimulatory bacterial transgene

por Viker, Kimberly B., Steele, Michael B., Iankov, Ianko D., Concilio, Susanna C., Ammayappan, Arun, Bolon, Brad, Jenks, Nathan J., Goetz, Matthew P., Panagioti, Eleni, Federspiel, Mark J., Liu, Minetta C., Peng, Kah Whye, Galanis, Evanthia
Publicado 2022

Oncolytic Virus with Attributes of Vesicular Stomatitis Virus and Measles Virus in Hepatobiliary and Pancreatic Cancers

por Nagalo, Bolni Marius, Breton, Camilo Ayala, Zhou, Yumei, Arora, Mansi, Bogenberger, James M., Barro, Oumar, Steele, Michael B., Jenks, Nathan J., Baker, Alexander T., Duda, Dan G., Roberts, Lewis Rowland, Russell, Stephen J., Peng, Kah Whye, Borad, Mitesh J.
Publicado 2020

Preclinical Development of Oncolytic Immunovirotherapy for Treatment of HPV(POS) Cancers

por Suksanpaisan, Lukkana, Xu, Rong, Tesfay, Mulu Z., Bomidi, Carolyn, Hamm, Stefan, Vandergaast, Rianna, Jenks, Nathan, Steele, Michael B., Ota-Setlik, Ayuko, Akhtar, Hinna, Luckay, Amara, Nowak, Rebecca, Peng, Kah Whye, Eldridge, John H., Clarke, David K., Russell, Stephen J., Diaz, Rosa Maria
Publicado 2018